Belite Bio (BLTE) Gains from Investment Securities (2020 - 2025)

Belite Bio's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$5000.0 for Q4 2025.

• In Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$5000.0; the TTM figure through Dec 2023 stood at $42000.0 (down 98.83% YoY), while the FY2025 annual figure was $23829.0, down 98.13% from the prior year.
• Gains from Investment Securities was -$5000.0 for Q4 2025 at Belite Bio, down from $42000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $3.6 million in Q4 2022 to a low of -$5000.0 in Q4 2025.
• Historically, Gains from Investment Securities has averaged $1.4 million across 4 years, with a median of $1.0 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities soared 80.39% in 2022, then slumped 98.83% in 2023.
• A 4-year view of Gains from Investment Securities shows it stood at $2.0 million in 2021, then jumped by 80.39% to $3.6 million in 2022, then plunged by 98.83% to $42000.0 in 2023, then sank by 111.9% to -$5000.0 in 2025.
• The last three Gains from Investment Securities figures came in at -$5000.0 (Q4 2025), $42000.0 (Q4 2023), and $3.6 million (Q4 2022), per Business Quant data.